Page last updated: 2024-08-26

bosentan anhydrous and Atrial Fibrillation

bosentan anhydrous has been researched along with Atrial Fibrillation in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bouras, G; Cleman, MW; Deftereos, S; Giannopoulos, G; Kaoukis, A; Panagopoulou, V; Papoutsidakis, N; Raisakis, K; Stefanadis, C1
Held, M; Jany, BH1

Reviews

1 review(s) available for bosentan anhydrous and Atrial Fibrillation

ArticleYear
The role of endothelin system in cardiovascular disease and the potential therapeutic perspectives of its inhibition.
    Current topics in medicinal chemistry, 2013, Volume: 13, Issue:2

    Topics: Animals; Atherosclerosis; Atrial Fibrillation; Bosentan; Cardiovascular Diseases; Coronary Artery Disease; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Humans; Hypertension, Pulmonary; Phenylpropionates; Predictive Value of Tests; Pyridazines; Receptors, Endothelin; Sulfonamides

2013

Other Studies

1 other study(ies) available for bosentan anhydrous and Atrial Fibrillation

ArticleYear
Pulmonary hypertension in COPD.
    Respiratory care, 2013, Volume: 58, Issue:8

    Topics: Aged; Antihypertensive Agents; Atrial Fibrillation; Bosentan; Comorbidity; Coronary Artery Disease; Exercise Test; Female; Humans; Hypertension, Pulmonary; Male; Pulmonary Diffusing Capacity; Pulmonary Disease, Chronic Obstructive; Sulfonamides; Treatment Outcome; Vasoconstriction; Vasoconstrictor Agents

2013